Erin T Wong1, Adam A Dmytriw1, Eugene Yu2, John Waldron3, Lin Lu4, Rouhi Fazelzad5, John R de Almeida6, Patrick Veit-Haibach1, Brian O'Sullivan3, Wei Xu4, Shao Hui Huang3. 1. Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada. 2. Department of Medical Imaging, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada. 3. Department of Radiation Oncology, Princess Margaret Cancer Centre / University of Toronto, Toronto, Ontario, Canada. 4. Biostatistics, University of Toronto, Toronto, Ontario, Canada. 5. Department of Library Sciences, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada. 6. Otolaryngology - Head & Neck Surgery, Princess Margaret Cancer Centre/University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE: To evaluate the performance of 18 F-fluorodeoxy-d-glucose positron emission tomography-computed tomography (18 F-FDG PET/CT) in identifying local failure and regional failure following curative radiotherapy or surgery for head and neck squamous cell carcinoma. METHODS: A comprehensive literature search identified studies published between January 2010 and August 2016. Diagnostic performance of 18 F-FDG PET/CT was evaluated for local failure/regional failure stratified by treatment-to-scan time interval of ≤3 versus >3 months. RESULTS: Twenty-four studies (2627 patients) were included. Compared to ≤3 months, 18 F-FDG PET/CT performed >3 months showed significantly improved sensitivity (87% vs 60%, P = 0.020) and specificity (93% vs 84%, P < 0.001) for local failure. There was no significant difference in sensitivity (79% vs 56%, P = 0.100) or specificity (95% vs 97%, P = 0.35) for regional failure >3 versus ≤3 months. CONCLUSIONS: This meta-analysis confirms high specificity but modest sensitivity of posttreatment 18 F-FDG PET/CT for local failure and regional failure. Sensitivity and specificity are significantly improved when 18 F-FDG PET/CT is performed >3 months for local failure.
PURPOSE: To evaluate the performance of 18 F-fluorodeoxy-d-glucose positron emission tomography-computed tomography (18 F-FDG PET/CT) in identifying local failure and regional failure following curative radiotherapy or surgery for head and neck squamous cell carcinoma. METHODS: A comprehensive literature search identified studies published between January 2010 and August 2016. Diagnostic performance of 18 F-FDG PET/CT was evaluated for local failure/regional failure stratified by treatment-to-scan time interval of ≤3 versus >3 months. RESULTS: Twenty-four studies (2627 patients) were included. Compared to ≤3 months, 18 F-FDG PET/CT performed >3 months showed significantly improved sensitivity (87% vs 60%, P = 0.020) and specificity (93% vs 84%, P < 0.001) for local failure. There was no significant difference in sensitivity (79% vs 56%, P = 0.100) or specificity (95% vs 97%, P = 0.35) for regional failure >3 versus ≤3 months. CONCLUSIONS: This meta-analysis confirms high specificity but modest sensitivity of posttreatment 18 F-FDG PET/CT for local failure and regional failure. Sensitivity and specificity are significantly improved when 18 F-FDG PET/CT is performed >3 months for local failure.
Authors: M Unterrainer; C Eze; H Ilhan; S Marschner; O Roengvoraphoj; N S Schmidt-Hegemann; F Walter; W G Kunz; P Munck Af Rosenschöld; R Jeraj; N L Albert; A L Grosu; M Niyazi; P Bartenstein; C Belka Journal: Radiat Oncol Date: 2020-04-21 Impact factor: 3.481
Authors: Zsuzsanna Iyizoba-Ebozue; Sarah Billingsley; Russell Frood; Sriram Vaidyanathan; Andrew Scarsbrook; Robin J D Prestwich Journal: Cancers (Basel) Date: 2022-09-26 Impact factor: 6.575
Authors: Qiongwen Zhang; Kai Wang; Zhiguo Zhou; Genggeng Qin; Lei Wang; Ping Li; David Sher; Steve Jiang; Jing Wang Journal: Front Oncol Date: 2022-09-29 Impact factor: 5.738